Inhibitory action of benzo[α]pyrene on hepatic lipoprotein receptors in Vitro and on liver lipid homeostasis in mice

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Layeghkhavidaki, Hamed ^a,b   Lanhers, Marie Claire ^a,b   Akbar, Samina ^a,b   Gregory Pauron, Lynn ^a,b   Oster, Thierry ^a,b   Grova, Nathalie ^c   Appenzeller, Brice ^c   Jasniewski, Jordane ^d   Feidt, Cyril ^a,b   Corbier, Catherine ^a,b   Yen, Frances T ^a,b,e  

^a UNIVERSITÉ DE LORRAINE   (France)

^b CEMAGREF   (France)

^c LUXEMBOURG INSTITUTE OF HEALTH   (Luxembourg)

^d UNIVERSITÉ DE LORRAINE   (France)

^e INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER A1; ABC TRANSPORTER G1; ACYL COENZYME A; ACYL COENZYME A CHOLESTEROL ACYLTRANSFERASE 1; ACYL COENZYME A CHOLESTEROL ACYLTRANSFERASE 2; BENZO[A]PYRENE; CHOLESTEROL ACYLTRANSFERASE; HIGH DENSITY LIPOPROTEIN; LACTACYSTIN; LIPOLYSIS STIMULATED LIPOPROTEIN RECEPTOR; LIPOPROTEIN RECEPTOR; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; MESSENGER RNA; SCAVENGER RECEPTOR BI; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; ANGULIN-1 PROTEIN, MOUSE; CHOLESTEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL LIVER LEVEL; CHOLESTEROL METABOLISM; CONTROLLED STUDY; IN VITRO STUDY; LIPID HOMEOSTASIS; LIVER; MALE; MOUSE; NONHUMAN; WEIGHT GAIN; ANIMAL; C57BL MOUSE; CELL LINE; CELL SURVIVAL; DRUG EFFECTS; HOMEOSTASIS; LIPID METABOLISM; METABOLISM;

ANIMALS; ATP BINDING CASSETTE TRANSPORTER 1; BENZO(A)PYRENE; CELL LINE; CELL SURVIVAL; CHOLESTEROL; HOMEOSTASIS; IN VITRO TECHNIQUES; LIPID METABOLISM; LIVER; MICE; MICE, INBRED C57BL; RECEPTORS, LDL; RECEPTORS, LIPOPROTEIN;

EID: 84904678764     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0102991     Document Type: Article

References (59)

1. Caballero B (2007) The global epidemic of obesity: an overview. Epidemiol Rev 29: 1-5.
2. Cunningham E (2010) Where can I find obesity statistics? J Am Diet Assoc 110: 656.
3. Howard BV, Ruotolo G, Robbins DC (2003) Obesity and dyslipidemia. Endocrinol Metab Clin North Am 32: 855-867. (Pubitemid 38029984)
4. Eckel RH (2011) The complex metabolic mechanisms relating obesity to hypertriglyceridemia. Arterioscler Thromb Vasc Biol 31: 1946-1948.
5. Brown MS, Goldstein JL (1986) A receptor-mediated pathway for cholesterol homeostasis. Science 232: 34-47. (Pubitemid 16037973)
6. Narvekar P, Berriel Diaz M, Krones-Herzig A, Hardeland U, Strzoda D, et al. (2009) Liver-specific loss of lipolysis-stimulated lipoprotein receptor triggers systemic hyperlipidemia in mice. Diabetes 58: 1040-1049.
7. Stenger C, Corbier C, Yen FT (2012) Structure and function of the lipolysis stimulated lipoprotein receptor. In: D Ekinci, editor editors. Chemical Biology. Rijeka: InTech. pp. 267-292.
8. Yen FT, Roitel O, Bonnard L, Notet V, Pratte D, et al. (2008) Lipolysis stimulated lipoprotein receptor: a novel molecular link between hyperlipidemia, weight gain, and atherosclerosis in mice. J Biol Chem 283: 25650-25659.
9. Schreyer SA, Vick C, Lystig TC, Mystkowski P, LeBoeuf RC (2002) LDL receptor but not apolipoprotein E deficiency increases diet-induced obesity and diabetes in mice. Am J Physiol Endocrinol Metab 282: E207-214.
10. Stenger C, Hanse M, Pratte D, Mbala ML, Akbar S, et al. (2010) Up-regulation of hepatic lipolysis stimulated lipoprotein receptor by leptin: a potential lever for controlling lipid clearance during the postprandial phase. Faseb J 24: 4218-4228.
11. Heindel JJ, vom Saal FS (2009) Role of nutrition and environmental endocrine disrupting chemicals during the perinatal period on the aetiology of obesity. Mol Cell Endocrinol 304: 90-96.
12. Schug TT, Janesick A, Blumberg B, Heindel JJ (2011) Endocrine disrupting chemicals and disease susceptibility. J Steroid Biochem Mol Biol 127: 204-215.
13. Hao C, Cheng X, Xia H, Ma X (2012) The endocrine disruptor mono-(2-ethylhexyl) phthalate promotes adipocyte differentiation and induces obesity in mice. Biosci Rep 32: 619-629.
14. Sargis RM, Johnson DN, Choudhury RA, Brady MJ (2010) Environmental endocrine disruptors promote adipogenesis in the 3T3-L1 cell line through glucocorticoid receptor activation. Obesity (Silver Spring) 18: 1283-1288.
15. Bostrom CE, Gerde P, Hanberg A, Jernstrom B, Johansson C, et al. (2002) Cancer risk assessment, indicators, and guidelines for polycyclic aromatic hydrocarbons in the ambient air. Environ Health Perspect 110 Suppl 3: 451-488. (Pubitemid 34669811)
16. Brevik A, Lindeman B, Rusnakova V, Olsen AK, Brunborg G, et al. (2012) Paternal benzo[α]pyrene exposure affects gene expression in the early developing mouse embryo. Toxicol Sci 129: 157-165.
17. Palanikumar L, Kumaraguru AK, Ramakritinan CM, Anand M (2011) Biochemical response of anthracene and benzo [α] pyrene in milkfish Chanos chanos. Ecotoxicol Environ Saf 75: 187-197.
18. EFSA (2008) Scientific opinion of the panel on contaminants in the food chain on a request from the European Commission on polycyclic aromatic hydrocarbons in food. The EFSA Journal 724: 1-114.
19. Hutcheon DE, Kantrowitz J, Van Gelder RN, Flynn E (1983) Factors affecting plasma benzo[α]pyrene levels in environmental studies. Environ Res 32: 104-110. (Pubitemid 14240601)
20. Irigaray P, Ogier V, Jacquenet S, Notet V, Sibille P, et al. (2006) Benzo[α]pyrene impairs beta-adrenergic stimulation of adipose tissue lipolysis and causes weight gain in mice. A novel molecular mechanism of toxicity for a common food pollutant. Febs J 273: 1362-1372. (Pubitemid 44029103)
21. Boysen G, Hecht SS (2003) Analysis of DNA and protein adducts of benzo[α]pyrene in human tissues using structure-specific methods. Mutat Res 543: 17-30. (Pubitemid 36050911)
22. Ekstrom G, von Bahr C, Glaumann H, Ingelman-Sundberg M (1982) Interindividual variation in benzo(a)pyrene metabolism and composition of isoenzymes of cytochrome P-450 as revealed by SDS-gel electrophoresis of human liver microsomal fractions. Acta Pharmacol Toxicol (Copenh) 50: 251-260. (Pubitemid 12074172)
23. Mitchell CE, Fischer JP, Dahl AR (1987) Differential induction of cytochrome P-450 catalyzed activities by polychlorinated biphenyls and benzo [α]pyrene in B6C3F1 mouse liver and lung. Toxicology 43: 315-323. (Pubitemid 17024455)
24. Fujisawa-Sehara A, Yamane M, Fujii-Kuriyama Y (1988) A DNA-binding factor specific for xenobiotic responsive elements of P-450c gene exists as a cryptic form in cytoplasm: its possible translocation to nucleus. Proc Natl Acad Sci U S A 85: 5859-5863.
25. Schmidt JV, Bradfield CA (1996) Ah receptor signaling pathways. Annu Rev Cell Dev Biol 12: 55-89. (Pubitemid 26422709)
26. Shimizu Y, Nakatsuru Y, Ichinose M, Takahashi Y, Kume H, et al. (2000) Benzo[α]pyrene carcinogenicity is lost in mice lacking the aryl hydrocarbon receptor. Proc Natl Acad Sci U S A 97: 779-782. (Pubitemid 30070386)
27. Busbee DL, Norman JO, Ziprin RL (1990) Comparative uptake, vascular transport, and cellular internalization of aflatoxin-B1 and benzo(a)pyrene. Arch Toxicol 64: 285-290. (Pubitemid 20185352)
28. Vauhkonen M, Kuusi T, Kinnunen PK (1980) Serum and tissue distribution of benzol[α]pyrene from intravenously injected chylomicrons in rat in vivo. Cancer Lett 11: 113-119. (Pubitemid 11179861)
29. Sureau F, Chinsky L, Duquesne M, Laigle A, Turpin PY, et al. (1990) Microspectrofluorimetric study of the kinetics of cellular uptake and metabolization of benzo(a)pyrene in human T 47D mammary tumor cells: evidence for cytochrome P1450 induction. Eur Biophys J 18: 301-307. (Pubitemid 20289680)
30. Verma N, Pink M, Petrat F, Rettenmeier AW, Schmitz-Spanke S (2012) Exposure of primary porcine urothelial cells to benzo(a)pyrene: in vitro uptake, intracellular concentration, and biological response. Arch Toxicol 86: 1861-1871.
31. Kelman BJ, Springer DL (1982) Movements of benzo[α]pyrene across the hemochorial placenta of the guinea pig. Proc Soc Exp Biol Med 169: 58-62. (Pubitemid 12121060)
32. Sarkadi B, Homolya L, Szakacs G, Varadi A (2006) Human multidrug resistance ABCB and ABCG transporters: participation in a chemoimmunity defense system. Physiol Rev 86: 1179-1236. (Pubitemid 44521651)
33. Sieuwerts AM, Klijn JG, Peters HA, Foekens JA (1995) The MTT tetrazolium salt assay scrutinized: how to use this assay reliably to measure metabolic activity of cell cultures in vitro for the assessment of growth characteristics, IC50-values and cell survival. Eur J Clin Chem Clin Biochem 33: 813-823.
34. Bratosin D, Mitrofan L, Palii C, Estaquier J, Montreuil J (2005) Novel fluorescence assay using calcein-AM for the determination of human erythrocyte viability and aging. Cytometry A 66: 78-84. (Pubitemid 40868922)
35. Mann CJ, Khallou J, Chevreuil O, Troussard AA, Guermani LM, et al. (1995) Mechanism of activation and functional significance of the lipolysis-stimulated receptor. Evidence for a role as chylomicron remnant receptor. Biochemistry 34: 10421-10431.
36. Ahmad N, Girardet JM, Akbar S, Lanhers MC, Paris C, et al. (2012) Lactoferrin and its hydrolysate bind directly to the oleate-activated form of the lipolysis stimulated lipoprotein receptor. Febs J 279: 4361-4373.
37. Daniel TO, Schneider WJ, Goldstein JL, Brown MS (1983) Visualization of lipoprotein receptors by ligand blotting. J Biol Chem 258: 4606-4611. (Pubitemid 13080687)
38. Peiffer J, Cosnier F, Grova N, Nunge H, Salquèbre G, et al. (2013) Neurobehavioral toxicity of a repeated exposure (14 days) to the airborne polycyclic aromatic hydrocarbon fluorene in adult Wistar male rats. PLoS One 8: e71413.
39. Grova N, Salquèbre G, Schroeder H, Appenzeller BM (2011) Determination of PAHs and OH-PAHs in rat brain by gas chromatography tandem (triple quadrupole) mass spectrometry. Chem Res Toxicol 24: 1653-1667.
40. Yen FT, Masson M, Clossais-Besnard N, Andre P, Grosset JM, et al. (1999) Molecular cloning of a lipolysis-stimulated remnant receptor expressed in the liver. J Biol Chem 274: 13390-13398.
41. Bihain BE, Yen FT (1992) Free fatty acids activate a high-affinity saturable pathway for degradation of low-density lipoproteins in fibroblasts from a subject homozygous for familial hypercholesterolemia. Biochemistry 31: 4628-4636.
42. Bihain BE, Deckelbaum RJ, Yen FT, Gleeson AM, Carpentier YA, et al. (1989) Unesterified fatty acids inhibit the binding of low density lipoproteins to the human fibroblast low density lipoprotein receptor. J Biol Chem 264: 17316-17321. (Pubitemid 19255562)
43. Huang M, Blair IA, Penning TM (2013) Identification of stable benzo[α]pyrene-7,8-dione-DNA adducts in human lung cells. Chem Res Toxicol 26: 685-692.
44. Pruess-Schwartz D, Baird WM, Nikbakht A, Merrick BA, Selkirk JK (1986) Benzo(a)pyrene:DNA adduct formation in normal human mammary epithelial cell cultures and the human mammary carcinoma T47D cell line. Cancer Res 46: 2697-2702. (Pubitemid 16074265)
45. Wu K, Shan YJ, Zhao Y, Yu JW, Liu BH (2001) Inhibitory effects of RRR-alpha-tocopheryl succinate on benzo(a)pyrene (B(a)P)-induced forestomach carcinogenesis in female mice. World J Gastroenterol 7: 60-65. (Pubitemid 32170899)
46. Pleil JD, Stiegel MA, Sobus JR, Tabucchi S, Ghio AJ, et al. (2010) Cumulative exposure assessment for trace-level polycyclic aromatic hydrocarbons (PAHs) using human blood and plasma analysis. J Chromatogr B Analyt Technol Biomed Life Sci 878: 1753-1760.
47. Chien YC, Yeh CT (2012) Excretion kinetics of urinary 3-hydroxybenzo[α]pyrene following dietary exposure to benzo[α]pyrene in humans. Arch Toxicol 86: 45-53.
48. Payan JP, Lafontaine M, Simon P, Marquet F, Champmargin-Gendre C, et al. (2009) 3-Hydroxybenzo(a)pyrene as a biomarker of dermal exposure to benzo(a)pyrene. Arch Toxicol 83: 873-883.
49. Miura H, Tomoda H, Miura K, Takishima K, Omura S (1996) Lactacystin increases LDL receptor level on HepG2 cells. Biochem Biophys Res Commun 227: 684-687. (Pubitemid 26387788)
50. Ogura M, Ayaori M, Terao Y, Hisada T, Iizuka M, et al. (2011) Proteasomal inhibition promotes ATP-binding cassette transporter A1 (ABCA1) and ABCG1 expression and cholesterol efflux from macrophages in vitro and in vivo. Arterioscler Thromb Vasc Biol 31: 1980-1987.
51. Chen Y, Wang H, Yu L, Yu X, Qian YW, et al. (2011) Role of ubiquitination in PCSK9-mediated low-density lipoprotein receptor degradation. Biochem Biophys Res Commun 415: 515-518.
52. Wang Y, Huang Y, Hobbs HH, Cohen JC (2012) Molecular characterization of proprotein convertase subtilisin/kexin type 9-mediated degradation of the LDLR. J Lipid Res 53: 1932-1943.
53. Nakanishi Y, Pei XH, Takayama K, Bai F, Izumi M, et al. (2000) Polycyclic aromatic hydrocarbon carcinogens increase ubiquitination of p21 protein after the stabilization of p53 and the expression of p21. Am J Respir Cell Mol Biol 22: 747-754. (Pubitemid 30400255)
54. Polyakov LM, Chasovskikh MI, Panin LE (1996) Binding and transport of benzo[α]pyrene by blood plasma lipoproteins: the possible role of apolipoprotein B in this process. Bioconjug Chem 7: 396-400. (Pubitemid 26312129)
55. Brown MS, Goldstein JL (1997) The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 89: 331-340. (Pubitemid 27220877)
56. de Faria E, Fong LG, Komaromy M, Cooper AD (1996) Relative roles of the LDL receptor, the LDL receptor-like protein, and hepatic lipase in chylomicron remnant removal by the liver. J Lipid Res 37: 197-209. (Pubitemid 26052631)
57. Ishibashi S, Perrey S, Chen Z, Osuga J, Shimada M, et al. (1996) Role of the low density lipoprotein (LDL) receptor pathway in the metabolism of chylomicron remnants. A quantitative study in knockout mice lacking the LDL receptor, apolipoprotein E, or both. J Biol Chem 271: 22422-22427. (Pubitemid 26304676)
58. Ebert B, Seidel A, Lampen A (2005) Identification of BCRP as transporter of benzo[α]pyrene conjugates metabolically formed in Caco-2 cells and its induction by Ah-receptor agonists. Carcinogenesis 26: 1754-1763. (Pubitemid 41487991)
59. Yang Y, Jiang Y, Wang Y, An W (2010) Suppression of ABCA1 by unsaturated fatty acids leads to lipid accumulation in HepG2 cells. Biochimie 92: 958-963.